TCMP
IOVA icon

Thrive Capital Management (Pennsylvania)’s Iovance Biotherapeutics IOVA Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,050
Closed -$33.5K – 178
2025
Q1 		$33.5K Hold
10,050
– – 0.02% 113
2024
Q4 		$74.4K Hold
10,050
– – 0.03% 95
2024
Q3 		$94.4K Hold
10,050
– – 0.04% 176
2024
Q2 		$80.6K Buy
10,050
+50
+0.5% +$536 0.04% 177
2024
Q1 		$148K Hold
10,000
– – 0.08% 118
2023
Q4 		$81.3K Hold
10,000
– – 0.04% 154
2023
Q3 		$45.5K Buy
+10,000
New +$65.3K 0.03% 135

Other funds holding IOVA

MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return